Global Ovarian Cancer Market Research Report 2023

Report ID: 1917451 | Published Date: Jan 2025 | No. of Page: 81 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Ovarian Cancer Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Surgery
        1.2.3 Chemotherapy
        1.2.4 Radiation
        1.2.5 Biological Therapy
    1.3 Market by Application
        1.3.1 Global Ovarian Cancer Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Ovarian Cancer Market Perspective (2017-2028)
    2.2 Ovarian Cancer Growth Trends by Region
        2.2.1 Ovarian Cancer Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Ovarian Cancer Historic Market Size by Region (2017-2022)
        2.2.3 Ovarian Cancer Forecasted Market Size by Region (2023-2028)
    2.3 Ovarian Cancer Market Dynamics
        2.3.1 Ovarian Cancer Industry Trends
        2.3.2 Ovarian Cancer Market Drivers
        2.3.3 Ovarian Cancer Market Challenges
        2.3.4 Ovarian Cancer Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Ovarian Cancer Players by Revenue
        3.1.1 Global Top Ovarian Cancer Players by Revenue (2017-2022)
        3.1.2 Global Ovarian Cancer Revenue Market Share by Players (2017-2022)
    3.2 Global Ovarian Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Ovarian Cancer Revenue
    3.4 Global Ovarian Cancer Market Concentration Ratio
        3.4.1 Global Ovarian Cancer Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Ovarian Cancer Revenue in 2021
    3.5 Ovarian Cancer Key Players Head office and Area Served
    3.6 Key Players Ovarian Cancer Product Solution and Service
    3.7 Date of Enter into Ovarian Cancer Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Ovarian Cancer Breakdown Data by Type
    4.1 Global Ovarian Cancer Historic Market Size by Type (2017-2022)
    4.2 Global Ovarian Cancer Forecasted Market Size by Type (2023-2028)
5 Ovarian Cancer Breakdown Data by Application
    5.1 Global Ovarian Cancer Historic Market Size by Application (2017-2022)
    5.2 Global Ovarian Cancer Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Ovarian Cancer Market Size (2017-2028)
    6.2 North America Ovarian Cancer Market Size by Country (2017-2022)
    6.3 North America Ovarian Cancer Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Ovarian Cancer Market Size (2017-2028)
    7.2 Europe Ovarian Cancer Market Size by Country (2017-2022)
    7.3 Europe Ovarian Cancer Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Ovarian Cancer Market Size (2017-2028)
    8.2 Asia-Pacific Ovarian Cancer Market Size by Country (2017-2022)
    8.3 Asia-Pacific Ovarian Cancer Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Ovarian Cancer Market Size (2017-2028)
    9.2 Latin America Ovarian Cancer Market Size by Country (2017-2022)
    9.3 Latin America Ovarian Cancer Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Ovarian Cancer Market Size (2017-2028)
    10.2 Middle East & Africa Ovarian Cancer Market Size by Country (2017-2022)
    10.3 Middle East & Africa Ovarian Cancer Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bristol Myers Squibb
        11.1.1 Bristol Myers Squibb Company Detail
        11.1.2 Bristol Myers Squibb Business Overview
        11.1.3 Bristol Myers Squibb Ovarian Cancer Introduction
        11.1.4 Bristol Myers Squibb Revenue in Ovarian Cancer Business (2017-2022)
        11.1.5 Bristol Myers Squibb Recent Development
    11.2 Eli Lilly
        11.2.1 Eli Lilly Company Detail
        11.2.2 Eli Lilly Business Overview
        11.2.3 Eli Lilly Ovarian Cancer Introduction
        11.2.4 Eli Lilly Revenue in Ovarian Cancer Business (2017-2022)
        11.2.5 Eli Lilly Recent Development
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Detail
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Ovarian Cancer Introduction
        11.3.4 GlaxoSmithKline Revenue in Ovarian Cancer Business (2017-2022)
        11.3.5 GlaxoSmithKline Recent Development
    11.4 Janssen Pharmaceuticals
        11.4.1 Janssen Pharmaceuticals Company Detail
        11.4.2 Janssen Pharmaceuticals Business Overview
        11.4.3 Janssen Pharmaceuticals Ovarian Cancer Introduction
        11.4.4 Janssen Pharmaceuticals Revenue in Ovarian Cancer Business (2017-2022)
        11.4.5 Janssen Pharmaceuticals Recent Development
    11.5 Novogen
        11.5.1 Novogen Company Detail
        11.5.2 Novogen Business Overview
        11.5.3 Novogen Ovarian Cancer Introduction
        11.5.4 Novogen Revenue in Ovarian Cancer Business (2017-2022)
        11.5.5 Novogen Recent Development
    11.6 Genentech
        11.6.1 Genentech Company Detail
        11.6.2 Genentech Business Overview
        11.6.3 Genentech Ovarian Cancer Introduction
        11.6.4 Genentech Revenue in Ovarian Cancer Business (2017-2022)
        11.6.5 Genentech Recent Development
    11.7 Aetera Zenteris
        11.7.1 Aetera Zenteris Company Detail
        11.7.2 Aetera Zenteris Business Overview
        11.7.3 Aetera Zenteris Ovarian Cancer Introduction
        11.7.4 Aetera Zenteris Revenue in Ovarian Cancer Business (2017-2022)
        11.7.5 Aetera Zenteris Recent Development
    11.8 Boehringer Ingelheim
        11.8.1 Boehringer Ingelheim Company Detail
        11.8.2 Boehringer Ingelheim Business Overview
        11.8.3 Boehringer Ingelheim Ovarian Cancer Introduction
        11.8.4 Boehringer Ingelheim Revenue in Ovarian Cancer Business (2017-2022)
        11.8.5 Boehringer Ingelheim Recent Development
    11.9 Roche
        11.9.1 Roche Company Detail
        11.9.2 Roche Business Overview
        11.9.3 Roche Ovarian Cancer Introduction
        11.9.4 Roche Revenue in Ovarian Cancer Business (2017-2022)
        11.9.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Ovarian Cancer Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Surgery
    Table 3. Key Players of Chemotherapy
    Table 4. Key Players of Radiation
    Table 5. Key Players of Biological Therapy
    Table 6. Global Ovarian Cancer Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Ovarian Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Ovarian Cancer Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Ovarian Cancer Market Share by Region (2017-2022)
    Table 10. Global Ovarian Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Ovarian Cancer Market Share by Region (2023-2028)
    Table 12. Ovarian Cancer Market Trends
    Table 13. Ovarian Cancer Market Drivers
    Table 14. Ovarian Cancer Market Challenges
    Table 15. Ovarian Cancer Market Restraints
    Table 16. Global Ovarian Cancer Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Ovarian Cancer Market Share by Players (2017-2022)
    Table 18. Global Top Ovarian Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ovarian Cancer as of 2021)
    Table 19. Ranking of Global Top Ovarian Cancer Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Ovarian Cancer Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Ovarian Cancer Product Solution and Service
    Table 23. Date of Enter into Ovarian Cancer Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Ovarian Cancer Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Ovarian Cancer Revenue Market Share by Type (2017-2022)
    Table 27. Global Ovarian Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Ovarian Cancer Revenue Market Share by Type (2023-2028)
    Table 29. Global Ovarian Cancer Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Ovarian Cancer Revenue Market Share by Application (2017-2022)
    Table 31. Global Ovarian Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Ovarian Cancer Revenue Market Share by Application (2023-2028)
    Table 33. North America Ovarian Cancer Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Ovarian Cancer Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Ovarian Cancer Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Ovarian Cancer Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Ovarian Cancer Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Ovarian Cancer Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Ovarian Cancer Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Ovarian Cancer Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Ovarian Cancer Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Ovarian Cancer Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Bristol Myers Squibb Company Detail
    Table 44. Bristol Myers Squibb Business Overview
    Table 45. Bristol Myers Squibb Ovarian Cancer Product
    Table 46. Bristol Myers Squibb Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 47. Bristol Myers Squibb Recent Development
    Table 48. Eli Lilly Company Detail
    Table 49. Eli Lilly Business Overview
    Table 50. Eli Lilly Ovarian Cancer Product
    Table 51. Eli Lilly Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 52. Eli Lilly Recent Development
    Table 53. GlaxoSmithKline Company Detail
    Table 54. GlaxoSmithKline Business Overview
    Table 55. GlaxoSmithKline Ovarian Cancer Product
    Table 56. GlaxoSmithKline Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 57. GlaxoSmithKline Recent Development
    Table 58. Janssen Pharmaceuticals Company Detail
    Table 59. Janssen Pharmaceuticals Business Overview
    Table 60. Janssen Pharmaceuticals Ovarian Cancer Product
    Table 61. Janssen Pharmaceuticals Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 62. Janssen Pharmaceuticals Recent Development
    Table 63. Novogen Company Detail
    Table 64. Novogen Business Overview
    Table 65. Novogen Ovarian Cancer Product
    Table 66. Novogen Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 67. Novogen Recent Development
    Table 68. Genentech Company Detail
    Table 69. Genentech Business Overview
    Table 70. Genentech Ovarian Cancer Product
    Table 71. Genentech Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 72. Genentech Recent Development
    Table 73. Aetera Zenteris Company Detail
    Table 74. Aetera Zenteris Business Overview
    Table 75. Aetera Zenteris Ovarian Cancer Product
    Table 76. Aetera Zenteris Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 77. Aetera Zenteris Recent Development
    Table 78. Boehringer Ingelheim Company Detail
    Table 79. Boehringer Ingelheim Business Overview
    Table 80. Boehringer Ingelheim Ovarian Cancer Product
    Table 81. Boehringer Ingelheim Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 82. Boehringer Ingelheim Recent Development
    Table 83. Roche Company Detail
    Table 84. Roche Business Overview
    Table 85. Roche Ovarian Cancer Product
    Table 86. Roche Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 87. Roche Recent Development
    Table 88. Research Programs/Design for This Report
    Table 89. Key Data Information from Secondary Sources
    Table 90. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Ovarian Cancer Market Share by Type: 2021 VS 2028
    Figure 2. Surgery Features
    Figure 3. Chemotherapy Features
    Figure 4. Radiation Features
    Figure 5. Biological Therapy Features
    Figure 6. Global Ovarian Cancer Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Others Case Studies
    Figure 10. Ovarian Cancer Report Years Considered
    Figure 11. Global Ovarian Cancer Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Ovarian Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Ovarian Cancer Market Share by Region: 2021 VS 2028
    Figure 14. Global Ovarian Cancer Market Share by Players in 2021
    Figure 15. Global Top Ovarian Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ovarian Cancer as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Ovarian Cancer Revenue in 2021
    Figure 17. North America Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Ovarian Cancer Market Share by Country (2017-2028)
    Figure 19. United States Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Ovarian Cancer Market Share by Country (2017-2028)
    Figure 23. Germany Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Ovarian Cancer Market Share by Region (2017-2028)
    Figure 31. China Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Ovarian Cancer Market Share by Country (2017-2028)
    Figure 39. Mexico Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Ovarian Cancer Market Share by Country (2017-2028)
    Figure 43. Turkey Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Bristol Myers Squibb Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 46. Eli Lilly Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 47. GlaxoSmithKline Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 48. Janssen Pharmaceuticals Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 49. Novogen Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 50. Genentech Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 51. Aetera Zenteris Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 52. Boehringer Ingelheim Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 53. Roche Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bristol Myers Squibb
Eli Lilly
GlaxoSmithKline
Janssen Pharmaceuticals
Novogen
Genentech
Aetera Zenteris
Boehringer Ingelheim
Roche
Frequently Asked Questions
Ovarian Cancer report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Ovarian Cancer report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Ovarian Cancer report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Overbed Tables

Overbed tables are narrow rectangular table which is especially designed for the patients in the  ... Read More

Ozone Generators

Ozone generators work by combining oxygen (O2) with energy to produce ozone (O3). When the oxygen ... Read More